IOLCP news

• 30-Oct-2026 20:17:14

  IOLCP Q2 : STANDALONE NET PROFIT UP 116.8% AT ₹65 CR (YOY), UP 0.8% (QOQ). STRONG (ON 1ST LOOK)

  Revenue up 40.1% at ₹795 Cr (YOY), up 5.1% (QOQ). Ebitda up 79.6% at ₹114.9 Cr (YOY), up 2.9% (QOQ); margins 14.4% v 11.1% (YOY), 14.8% (QOQ). PAT margin 8.1%…

• 30-Oct-2026 20:09:53

  IOLCP Q2 : STANDALONE NET PROFIT UP 116.8% AT ₹65 CR (YOY)

  • Revenue up 40.1% at ₹795 Cr (YoY); H1 up 38.6%. • EBITDA up 79.6% at ₹114.9 Cr (YoY); margins 14.4% v 11.1% (YoY), H1 14.5% v 11.8%. • PAT margin 8.1% v 5.2%…

• 30-Oct-2026 18:01:18

  IOL CHEMICALS Q2 FY27 ; NET PROFIT UP 116.67% AT ₹65 CR (YOY), UP 1.56% (QOQ)

  REVENUE UP 39.96% AT ₹795 CR (YOY), UP 5.16% (QOQ) EBITDA UP 91.23% AT ₹109 CR (YOY), UP 5.83% (QOQ) MARGINS AT 13.71% VS 10.04% (YOY), 13.62% (QOQ)

• 25-Sept-2026 13:32:34

  IOL CHEMICALS GRANTED CEP FOR FENOFIBRATE - PROCESS II

  • European Directorate for the Quality of Medicines & HealthCare (EDQM) granted a Certificate of Suitability (CEP) on 24th September 2026 for the Company's Act…

• 23-Sept-2026 16:12:27

  IOL CHEMICALS : EU-REACH REGISTRATION FOR TRIACETIN RECEIVED

  • Company has received REACH certification/registration for its product Triacetin under the applicable EU-REACH framework. • This certification enables the com…

• 09-Sept-2026 14:34:05

  IOL CHEMICALS EXPANDSPRODUCTION CAPACITY

  • Company setting up a new manufacturing unit for Ibuprofen with an installed capacity of 6,000 MT per annum. • This will enhance existing Ibuprofen capacity f…

← Back to feed